...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Structural basis for agonism and antagonism of hepatocyte growth factor
【24h】

Structural basis for agonism and antagonism of hepatocyte growth factor

机译：肝细胞生长因子拮抗作用的结构基础

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Hepatocyte growth factor (HGF) is an activating ligand of the Met receptor tyrosine kinase, whose activity is essential for normal tissue development and organ regeneration but abnormal activation of Met has been implicated in growth, invasion, and metastasis of many types of solid tumors. HGF has two natural splice variants, NK1 and NK2, which contain the N-terminal domain (N) and the first kringle (K1) or the first two kringle domains of HGF. NK1, which is a Met agonist, forms a head-to-tail dimer complex in crystal structures and mutations in the NK1 dimer interface convert NK1 to a Met antagonist. In contrast, NK2 is a Met antagonist, capable of inhibiting HGF's activity in cell proliferation without clear mechanism. Here we report the crystal structure of NK2, which forms a "closed" monomeric conformation through interdomain interactions between the N- domain and the second kringle domain (K2). Mutations that were designed to open up the NK2 closed conformation by disrupting the N/K2 interface convert NK2 from a Met antagonist to an agonist. Remarkably, this mutated NK2 agonist can be converted back to an antagonist by a mutation that disrupts the NK1/NK1 dimer interface. These results reveal the molecular determinants that regulate the agonist/antagonist properties of HGF NK2 and provide critical insights into the dimerization mechanism that regulates the Met receptor activation by HGF.
机译：肝细胞生长因子（HGF）是Met受体酪氨酸激酶的激活配体，其活性对于正常组织发育和器官再生必不可少，但Met的异常激活与多种类型实体瘤的生长，侵袭和转移有关。 HGF具有两个天然剪接变体NK1和NK2，它们包含HGF的N末端域（N）和第一个kringle（K1）或前两个kringle域。 NK1是Met激动剂，在晶体结构中形成从头到尾的二聚体复合物，NK1二聚体界面中的突变将NK1转化为Met拮抗剂。相反，NK2是一种Met拮抗剂，能够抑制HGF在细胞增殖中的活性而没有明确的机制。在这里，我们报告NK2的晶体结构，该结构通过N-域和第二个Kringle域（K2）之间的域间相互作用形成“封闭的”单体构象。通过破坏N / K2界面来打开NK2闭合构象的突变将NK2从Met拮抗剂转变为激动剂。值得注意的是，这种突变的NK2激动剂可以通过破坏NK1 / NK1二聚体界面的突变转化回拮抗剂。这些结果揭示了调节HGF NK2激动剂/拮抗剂特性的分子决定簇，并为调节Het激活Met受体的二聚化机制提供了重要的见识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号